Patents-Review.com
🔗 Permalink
Assignee profile:

Union Therapeutics A/S

City:

Hellerup

Country:

Denmark

Published Applications:

22

Last publication date:

2025-03-20

Patent Grants:

21

Last grant date:

2025-09-09

Top Inventors for applications by Union Therapeutics A/S

These are the the leading inventors for applications assigned to Union Therapeutics A/S:

Recent patent applications by Union Therapeutics A/S

Union Therapeutics A/S based in Hellerup, DK has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-03-20 ✅ Patent 12,409,172 granted on 2025-09-09
US20250090512A1
Human necessities

Dosage Regimen

 #2 | 2023-03-23 ✅ Patent 11,981,681 granted on 2024-05-14
US20230087354A1
Chemistry; metallurgy

Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors

 #3 | 2022-09-08 ✅ Patent 11,866,445 granted on 2024-01-09
US20220281889A1
Chemistry; metallurgy

Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors

 #4 | 2022-05-26 ✅ Patent 12,084,457 granted on 2024-09-10
US20220162227A1
Chemistry; metallurgy

Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

 #5 | 2022-05-10 ✅ Patent 11,324,708 granted on 2022-05-10
US17330067
Human necessities

Niclosamide formulations for treating disease

 #6 | 2021-12-16
US20210386674A1
Human necessities

MODIFIED RELEASE TABLET FORMULATIONS CONTAINING PHOSPHODIESTERASE INHIBITOR

 #7 | 2021-10-07 ✅ Patent 11,529,361 granted on 2022-12-20
US20210308153A1
Human necessities

Halogenated salicylanilides for treating infections

 #8 | 2021-05-20 ✅ Patent 11,220,514 granted on 2022-01-11
US20210147440A1
Chemistry; metallurgy

Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

 #9 | 2021-03-18 ✅ Patent 11,384,096 granted on 2022-07-12
US20210079012A1
Chemistry; metallurgy

Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors

 #10 | 2021-03-11 ✅ Patent 11,292,799 granted on 2022-04-05
US20210070769A1
Chemistry; metallurgy

Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors

 #11 | 2020-12-10 ✅ Patent 11,299,497 granted on 2022-04-12
US20200385400A1
Chemistry; metallurgy

Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitors

 #12 | 2020-10-15 ✅ Patent 11,331,289 granted on 2022-05-17
US20200323801A1
Human necessities

Antimicrobial composition

 #13 | 2020-10-01 ✅ Patent 11,324,761 granted on 2022-05-10
US20200306271A1
Human necessities

Antibacterial use of halogenated salicylanilides

 #14 | 2020-10-01 ✅ Patent 11,331,327 granted on 2022-05-17
US20200306270A1
Human necessities

Antibacterial use of halogenated salicylanilides

 #15 | 2020-10-01 ✅ Patent 11,285,164 granted on 2022-03-29
US20200306269A1
Human necessities

Antibacterial use of halogenated salicylanilides

 #16 | 2020-08-20 ✅ Patent 11,370,799 granted on 2022-06-28
US20200262842A1
Chemistry; metallurgy

Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

 #17 | 2020-07-30 ✅ Patent 11,365,204 granted on 2022-06-21
US20200239493A1
Chemistry; metallurgy

Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors

 #18 | 2020-03-26 ✅ Patent 10,857,164 granted on 2020-12-08
US20200093839A1
Human necessities

Halogenated salicylanilides for treating infections

 #19 | 2019-07-04 ✅ Patent 11,213,533 granted on 2022-01-04
US20190201422A1
Human necessities

Combinations comprising dibromopropamidine or diminazene and a tetracycline anti-bacterial agent

 #20 | 2019-05-23 ✅ Patent 12,036,312 granted on 2024-07-16
US20190151231A1
Human necessities

Non-aqueous topical compositions comprising a halogenated salicylanilide

 #21 | 2019-04-04 ✅ Patent 10,758,553 granted on 2020-09-01
US20190099433A1
Human necessities

Antibacterial use of halogenated salicylanilides

 #22 | 2018-07-26 ✅ Patent 10,463,680 granted on 2019-11-05
US20180207179A1
Human necessities

Halogenated salicylanilides for treating clostridium infections

Also check out UNION therapeutics A/S's (Hellerup, Denmark) applicant profile with 23 patent applications submitted.

AssigneeID:

148577 ⎘